DE60132637D1 - Verfahren zur herstellung von pyrimidinonverbindungen und deren pharmazeutisch unbedenklichen salzen - Google Patents

Verfahren zur herstellung von pyrimidinonverbindungen und deren pharmazeutisch unbedenklichen salzen

Info

Publication number
DE60132637D1
DE60132637D1 DE60132637T DE60132637T DE60132637D1 DE 60132637 D1 DE60132637 D1 DE 60132637D1 DE 60132637 T DE60132637 T DE 60132637T DE 60132637 T DE60132637 T DE 60132637T DE 60132637 D1 DE60132637 D1 DE 60132637D1
Authority
DE
Germany
Prior art keywords
pharmaceuticalally
salts
production
pyrimidinone compounds
pyrimidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132637T
Other languages
English (en)
Other versions
DE60132637T2 (de
Inventor
Sang-Lin Kim
Ji-Han Kim
Jung-Bok Lee
Byoung-Wug Yoo
Hyun-Kwang Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boryung Pharmaceutical Co Ltd
Original Assignee
Boryung Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boryung Pharmaceutical Co Ltd filed Critical Boryung Pharmaceutical Co Ltd
Publication of DE60132637D1 publication Critical patent/DE60132637D1/de
Application granted granted Critical
Publication of DE60132637T2 publication Critical patent/DE60132637T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60132637T 2001-09-21 2001-09-21 Verfahren zum herstellen von pyrimidionverbindungen und deren pharmazeutisch unbedenklichen salzen Expired - Lifetime DE60132637T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2001/001583 WO2003024956A1 (en) 2001-09-21 2001-09-21 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof

Publications (2)

Publication Number Publication Date
DE60132637D1 true DE60132637D1 (de) 2008-03-13
DE60132637T2 DE60132637T2 (de) 2009-01-15

Family

ID=19198449

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132637T Expired - Lifetime DE60132637T2 (de) 2001-09-21 2001-09-21 Verfahren zum herstellen von pyrimidionverbindungen und deren pharmazeutisch unbedenklichen salzen

Country Status (9)

Country Link
US (1) US7309788B2 (de)
EP (1) EP1436283B1 (de)
JP (1) JP4268871B2 (de)
CN (1) CN1273465C (de)
AU (1) AU2001292386B2 (de)
CA (1) CA2461060C (de)
DE (1) DE60132637T2 (de)
MX (1) MXPA04002653A (de)
WO (1) WO2003024956A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2726811C (en) 2008-06-06 2019-11-26 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Survival predictor for diffuse large b cell lymphoma
KR101058284B1 (ko) 2010-01-22 2011-08-22 보령제약 주식회사 2-(2-n-부틸-4-히드록시-6-메틸-피리미딘-5-일)-N,N-디메틸아세트아미드의 신규한 제조방법
CN104610164B (zh) * 2010-01-21 2018-03-16 保宁制药株式会社 2‑(2‑正丁基‑4‑羟基‑6‑甲基‑嘧啶‑5‑基)‑n,n‑二甲基乙酰胺的制备方法
KR101226332B1 (ko) 2010-01-21 2013-01-24 보령제약 주식회사 2-(2-n-부틸-4-히드록시-6-메틸-피리미딘-5-일)-N,N-디메틸아세트아미드의 신규한 제조방법
CN102485227B (zh) * 2010-12-02 2015-06-10 鲁南制药集团股份有限公司 一种药物组合物及其用途
CN102485228B (zh) * 2010-12-02 2015-06-10 鲁南制药集团股份有限公司 一种药物组合物及其用途
US8765776B2 (en) * 2011-04-12 2014-07-01 Boryung Pharmaceutical Co., Ltd. Antihypertensive pharmaceutical composition
KR101490329B1 (ko) * 2012-10-12 2015-02-04 보령제약 주식회사 피마살탄 포타슘염의 일수화물 결정, 그 제조방법, 및 그를 포함하는 약제학적 조성물
PT2968316T (pt) 2013-03-13 2019-10-29 Forma Therapeutics Inc Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro
EP3066215B1 (de) 2013-11-06 2019-04-24 The United States of America, represented by the Secretary, Department of Health and Human Services Methode zur lymphoma typisierung mit hilfe von expressionsmarker bestimmung
CN105837514B (zh) * 2016-01-29 2018-09-18 北京睿创康泰医药研究院有限公司 非马沙坦药物杂质的制备方法
CN107586289A (zh) * 2017-09-13 2018-01-16 潍坊新益制药技术有限公司 非马沙坦钾盐三水合物的制备方法
CN107973784B (zh) * 2017-11-16 2021-08-24 珠海市海瑞德生物科技有限公司 一种非马沙坦的合成方法
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
CN113382633A (zh) 2018-10-29 2021-09-10 福马治疗股份有限公司 (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式
CN109485640B (zh) * 2018-12-24 2021-03-26 合肥创新医药技术有限公司 一种非马沙坦杂质的制备方法
KR102221856B1 (ko) * 2020-10-12 2021-03-02 유니셀랩 주식회사 신규한 피마살탄 결정형의 다형체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100300566B1 (ko) * 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도
KR19990081093A (ko) * 1998-04-25 1999-11-15 조생현 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및 이의제조방법

Also Published As

Publication number Publication date
CN1273465C (zh) 2006-09-06
EP1436283B1 (de) 2008-01-23
WO2003024956A1 (en) 2003-03-27
CA2461060C (en) 2010-07-27
CN1558906A (zh) 2004-12-29
DE60132637T2 (de) 2009-01-15
EP1436283A4 (de) 2004-12-08
US20040266800A1 (en) 2004-12-30
US7309788B2 (en) 2007-12-18
EP1436283A1 (de) 2004-07-14
CA2461060A1 (en) 2003-03-27
AU2001292386B2 (en) 2006-06-22
MXPA04002653A (es) 2004-07-08
JP2005504800A (ja) 2005-02-17
JP4268871B2 (ja) 2009-05-27

Similar Documents

Publication Publication Date Title
DE122007000077I2 (de) Verfahren zur herstellung von substituierten octanoyl-amiden
DE60238793D1 (de) Verfahren zur Herstellung von Polyesterhärzen
DE50208864D1 (de) Verfahren zur herstellung von arylaminen
DE60132637D1 (de) Verfahren zur herstellung von pyrimidinonverbindungen und deren pharmazeutisch unbedenklichen salzen
DE60138099D1 (de) Verfahren zur herstellung von substituierten octanoyl-amiden
DE60002793D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE50000852D1 (de) Verfahren zur Herstellung von Aminen
AT7110U3 (de) Verfahren zur herstellung von amlodipinmaleat
DE50001321D1 (de) Verfahren zur Herstellung von Vinylencarbonat und dessen Verwendung
ATE288911T1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE60222645D1 (de) Verfahren zur herstellung von oxazolidinonen
DE60229194D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60001238D1 (de) Verfahren zur Herstellung von Sulfonimiden oder deren Salzen
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
DE50205766D1 (de) Verfahren zur herstellung von 2-halogenpyridincarbonsäureamiden
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
DE60202261D1 (de) Verfahren zur herstellung von mesylaten von piperazinderivaten
DE60219800D1 (de) Verfahren zur herstellung von cilastatin
DE50213632D1 (de) Verfahren zur Herstellung von registergenau gedruckten Multilayer-Aufbauten
DE60019606D1 (de) Verfahren zur herstellung von substituierten pyrimidinen
DE60214469D1 (de) Verfahren zur Herstellung von Zirkoniapulver
DE60127652D1 (de) Ökologisches verfahren zur herstellung von sehr reinem tetrabrombisphenol-a
DE60217414D1 (de) Verfahren zur Herstellung von Alpha-Hydroxycarbonsäure Amiden
DE60131562D1 (de) Verfahren zur herstellung von benztriazolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition